VEGFA and ovarian hyperstimulation syndrome: In conclusion, the present study reveals that KS may be a novel potential drug candidate for preventing OHSS in clinical practice in which KS can suppress VEGF expression to decrease vascular permeability, and thus alleviated OHSS development without side effects on reproductive function of mice.